Pfizer ($PFE) CEO Ian Read (photo) told the Financial Times that he hopes to divest the company's animal health and nutrition units by June 13, gaining cash to finance new bolt-on acquisitions and return money to shareholders. Report
The study focuses on Life Science organizations' quality & compliance trends and best practices making the connection through training effectiveness, metrics and continuous improvement. Learn what these trends mean for 2014 and what the FDA's most cited learning priorities were in 2013. Download Now.
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join 100,000+ pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!